- Home
- TPG vs NOVT Comparison
TPG vs NOVT Comparison
Compare TPG & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TPG | NOVT |
|---|---|---|
| Founded | 1992 | 1968 |
| Country | United States | United States |
| Employees | 1900 | N/A |
| Industry | Investment Managers | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 5.7B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | TPG | NOVT |
|---|---|---|
| Price | $42.76 | $141.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 1 |
| Target Price | $61.20 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 1.7M | 476.8K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | $19.79 | $6.57 |
| P/E Ratio | ★ $106.82 | $280.90 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $36.95 | $98.27 |
| 52 Week High | $70.38 | $171.85 |
Technical Indicators
Market Signals| Indicator | TPG | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 39.04 |
| Support Level | $41.43 | $131.26 |
| Resistance Level | $45.97 | $149.42 |
| Average True Range (ATR) | 1.26 | 7.51 |
| MACD | -0.03 | -1.16 |
| Stochastic Oscillator | 34.73 | 8.18 |
Price Performance
Historical ComparisonAbout TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms, namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, market solutions, innovation, and inclusion.
About NOVT Novanta Inc.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.